hydrochlorothiazide

Key facts

INN

hydrochlorothiazide

Brand

LISINOPRIL AND HYDROCHLOROTHIAZIDE

Route

ORAL

Formulation

CAPSULE

Originator

Amneal Pharmaceuticals

Related patents

patent

US 10722581

Phonophoretic cannabidiol composition and transdermal delivery system

Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10398776

Phonophoretic cannabidiol composition and transdermal delivery system

Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9592291

Methods for iontophoretically treating nausea and migraine

Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9427578

Pharmacokinetics of iontophoretic sumatriptan administration

Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 8530621

Combined preparation of a thiazide diuretic and a loop diuretic

Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 8067636

Dihydrazide compounds, preparation and uses thereof

Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 7906513

Hydrazide-containing hepatitis C serine protease inhibitors

Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 7888332

Hydrazide-containing CFTR inhibitor compounds and uses thereof

Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is hydrochlorothiazide?

hydrochlorothiazide (LISINOPRIL AND HYDROCHLOROTHIAZIDE), is a pharmaceutical active ingredient, associated with Amneal Pharmaceuticals, with approved status in the US.

What is the brand name for hydrochlorothiazide?

LISINOPRIL AND HYDROCHLOROTHIAZIDE is a marketed brand name for hydrochlorothiazide. Check FDA Drugs@FDA for the current US label holder.